Interacting Drugs |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Conivaptan |
Security Level |
|
Mechanism |
Conivaptan: May increase the serum concentration of CYP3A4 Substrates (Low risk). |
Management |
Monitor therapy |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Conivaptan
Post Review about Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Conivaptan Click here to cancel reply.
Other Interactions of Bacitracin, neomycin, polymyxin B, and hydrocortisone
Other Interactions of Conivaptan
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.